Small Molecules

15 May 2007 GSK Returns Development Rights for MED2002
12 May 2007 NicOx Provides An Update On The Phase 2a Study For NCX 1000 Conducted With Axcan
12 May 2007 Merck Receives Approvable Letter from FDA for EMEND(R) (fosaprepitant dimeglumine) For Injection
11 May 2007 FDA Approves Schwarz Pharma's Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
11 May 2007 ZIOPHARM Treats First Patient in Phase II ZIO-101 Liver Cancer Trial
11 May 2007 Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for Obesity
11 May 2007 Molecular Insight Pharmaceuticals, Inc. Initiates Azedra(TM) Therapeutic Trial in Neuroendocrine Cancer Patients
10 May 2007 Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
10 May 2007 Curis Provides Update on Hedgehog Agonist Hair Growth Program
10 May 2007 IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
10 May 2007 Tapestry Pharmaceuticals Announces Phase II Clinical Program for TPI 287
10 May 2007 Somaxon Pharmaceuticals Provides Update on Silenor Development Program
09 May 2007 4SC AG Provides Proof of Concept for Drug Candidate SC75741 in the Treatment of Influenza A-infected Mice
09 May 2007 Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
09 May 2007 Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
09 May 2007 ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
08 May 2007 Adverse event with oral EPO FG-2216 in anemia treatment
08 May 2007 Isotechnika announces interim three month data from Phase 2b kidney transplant trial
08 May 2007 Nymox Announces New Positive Results from 3 1/2 Year Study of NX-1207 for Benign Prostatic Hyperplasia
08 May 2007 SRI International Reacquires Rights to Tirapazamine, a Phase III Cancer Drug
08 May 2007 Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results For AT-1001 For The Treatment Of Celiac Disease
08 May 2007 Genaera Corporation Initiates Human Study Of Obesity Compound Trodusquemine
08 May 2007 Bema(TM) Fentanyl Demonstrates Substantial Transmucosal Delivery In Absolute Bioavailability Study
08 May 2007 CollaGenex Pharmaceuticals Discontinues 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne
08 May 2007 Gemin X Initiates a Phase 1 Trial with GMX1777 in Solid Tumors and Lymphomas

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up